Get the Stockscreener App
0.7933
2.09%
-0.0169
Pre-market:
.77
-0.0233
-2.94%
Creative Medical Technology Holdings Inc stock is traded at $0.7933, with a volume of 99,037.
It is down -2.09% in the last 24 hours and down -33.89% over the past month.
Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.
See More
Previous Close:
$0.8102
Open:
$0.7912
24h Volume:
99,037
Relative Volume:
0.03
Market Cap:
$5.15M
Revenue:
$3,000
Net Income/Loss:
$-5.76M
P/E Ratio:
-0.4295
EPS:
-1.8471
Net Cash Flow:
$-5.59M
1W Performance:
-8.08%
1M Performance:
-33.89%
6M Performance:
-63.27%
1Y Performance:
-70.73%
1-Day Range:
$0.77
$0.8102
1-Week Range:
$0.77
$0.8996
52-Week Range:
$0.77
$6.25
Creative Medical Technology Holdings Inc Stock (CELZ) Company Profile
Name
Creative Medical Technology Holdings Inc
Sector
Industry
Phone
480-399-2822
Address
211 E. OSBORN RD., PHOENIX
Compare CELZ vs VRTX, REGN, ARGX, RVMD, ALNY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CELZ
Creative Medical Technology Holdings Inc
|
0.7933 | 5.15M | 3,000 | -5.76M | -5.59M | -1.8471 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 37.17B | 4.29B | 577.22M | 641.34M | 4.2086 |
Creative Medical Technology Holdings Inc Stock (CELZ) Latest News
Creative Medical Technology Holdings Inc (CELZ) Cash Flow - TradingKey
Creative Medical Technology Holdings Inc (CELZ) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Creative Medical Technology Holdings Inc (CELZ) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Creative Medical Technology Holdings Inc (CELZ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Creative Medical Technology Holdings Inc (CELZ) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Creative Medical Technology Holdings Inc - TradingKey
Creative Medical Technology Holdings Inc (CELZ) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Healthcare Demand Upgrade, EPS Creative Health Technology Group (3860.HK) Expands Its Healthcare Business - IT Business Net
Creative Medical Technology (NASDAQ: CELZ) files S-3 for 5.58M warrant-share resale - Stock Titan
TradingKey - TradingKey
Healthcare Demand Upgrade, EPS Creative Health Technology Group - GuruFocus
Creative Medical Technology Holdings Inc (CELZ) Institutional Confidence - TradingKey
BioAdaptives Outlines Xcellara Platform Strategy Ahead of XcellaraHeart Launch - Yahoo Finance
Creative Medical Technology Holdings Inc. (CELZ) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Creative Medical Technology (CELZ) plans big share boost and warrant approval - Stock Titan
Creative Medical Technology (CELZ) Slides 3% as Stock Tests Key Support LevelDividend Arbitrage - dars.gov.et
WOK Stock Quote Price and Forecast - CNN
Why Smart Traders Take Profits Into Strength - Banyan Hill Publishing
MEDIPOST Inc. Treats First U.S. Participant in Phase III Trial of Umbilical Cord Stem Cell Therapy for Symptomatic Cartilage Defects Due to Knee Osteoarthritis - Yahoo Finance
Texas Biomed Signs Agreement to Strengthen U.S. Biodefense Capabilities - Yahoo Finance
Creative Medical Technology enters into agreement with warrant holders - Medical Buyer
Creative Medical Technology enters into agreement with existing warrant holders - Medical Buyer
symbol__ Stock Quote Price and Forecast - CNN
Creative Medical Technology Announces Warrant Inducement Financing Agreements - TipRanks
Creative Medical Technology Raises $4.5M From Warrant Exercises, Reprices and Issues New 5-Year Warrants - TradingView
Creative Medical (CELZ) secures $4.5M and issues 5.58M inducement warrants - Stock Titan
Hologic removes BioZorb 3D bioabsorbable markers due to safety reasons - Medical Buyer
Why Constellation Brands Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Sahm
Creative Medical Technology awards $100,000 bonus to CEO Timothy Warbington - TradingView
Creative Medical (CELZ) asks shareholders to OK 5.58M warrants, 100M cap increase - Stock Titan
HOV Q2 2026 Earnings: Narrower-Than-Expected Loss Drives Surprise but Stock DeclinesEPS Estimate Trend - dars.gov.et
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Creative Medical provides mid-year business update By Investing.com - Investing.com Australia
Creative Medical provides mid-year business update - Investing.com
Creative Medical Technology Holdings Issues Mid-Year Update - The Manila Times
Creative Medical says FDA-cleared pain trial is 85% enrolled - Stock Titan
12 Health Care Stocks Moving In Wednesday's Pre-Market SessionCan Fite Biopharma (AMEX:CANF), Atlantic - Benzinga
Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.5 Million Gross Proceeds - The Manila Times
ADRMD Stock Price and Chart — OTC:ADRMD - TradingView
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Creative Medical secures $4.5M through warrant exercise deal - Investing.com
Creative Medical secures $4.5M through warrant exercise deal By Investing.com - Investing.com India
Creative Medical (CELZ) Secures $4.5M from Immediate Warrant Exe - GuruFocus
Creative Medical Technology Holdings Announces Immediate Exercise of Warrants for Approximately $4.5 Million in Gross Proceeds | CELZ Stock News - Quiver Quantitative
Creative Medical locks in $4.5M from warrant holders - Stock Titan
CELZCreative Medical Technology Holdings Inc Forecast, Target Price - Finviz
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
CELZ jumps before FDA update as traders weigh dilution math - TechStock²
Nasdaq Gains Over 300 Points; Chicago PMI Falls In June - Benzinga
Trending Stocks Today | Creative Medical Technology Shoots up 325.54% - Moomoo
Creative Medical Technology Holdings surges as traders appear to chase recent clinical and platform updates - Quiver Quantitative
Creative Medical Technology Holdings Inc Stock (CELZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.97%
0.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):